Neoadjuvant Treatment of HER2 Positive Early High-risk and Locally Advanced Breast Cancer
Clinical trial NCT03595592 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03595592
- Sponsor
- Fondazione Michelangelo
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-07
- Primary completion
- 2026-12-15
- Enrollment
- 650
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.